Tarsus Pharmaceuticals Inc (TARS)

NASDAQ HEALTHCARE
$59.04 -0.84% Daily RSI (14) 47 Neutral As of Jul 31, 2026 Add Alert

Moving Averages

SMA 200
$68.98
Price below

Company Profile

Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates for ophthalmic conditions. The company is headquartered in Irvine, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$2.54B
P/E Ratio
None
EPS
$-1.11
Beta
0.499
Dividend Yield
0.00%
52-Week High
$85.25
52-Week Low
$38.51

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 46.0
VRTX
Vertex Pharmaceuticals Inc
RSI 48.0
CRSP
CRISPR Therapeutics AG
RSI 42.0
MRNA
Moderna Inc
RSI 41.0
VKTX
Viking Therapeutics Inc
RSI 36.0
SRPT
Sarepta Therapeutics Inc
RSI 32.0
EDIT
Editas Medicine Inc
RSI 39.0
IOVA
Iovance Biotherapeutics Inc
RSI 42.0
NVAX
Novavax Inc
RSI 30.0
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 46.0

Data last updated: July 14, 2026 at 2:04 AM EDT

Track TARS for free

Get e-mail RSI alerts when Tarsus Pharmaceuticals Inc enters oversold or overbought territory. Free forever.

Add Alert